Cardiff Oncology Inc (CRDF)

SG&A Expense Growth

-37.90%

Quarterly · Period ending:

CRDF logo

CRDF SG&A Expense Growth

Latest reported-37.90%
CRDF Quarterly SG&A Growth (QoQ) (0.00% → -37.90%)
High-resolution chart · PNG

CRDF sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-37.904%
104.5409%
-23.146%
0%
-100%
33.3112%
0%
-100%
6.1757%
11.1193%
-7.2814%
-31.5875%
39.3448%
0.1624%
0.0325%
-0.2916%
-21.6751%
2.7379%
30.8874%
3.2417%
26.9799%
-34.592%
107.8476%
-1.4979%
12.3149%
154.5103%
-194.6336%
88.526%
3.5932%
-12.4629%
1.189%
-22.5802%
-14.1361%
33.6701%
-54.0632%
-12.7218%
29.671%
-23.1096%
-17.0507%
0.9625%
-20.7317%
72.281%
9.3998%
-4.3693%
50.6553%
-4.0355%
35.0156%
5.6379%
-1.4531%
19.7361%
-27.0036%
49.1251%
-13.327%
70.1612%
35.7162%
-8.7454%
-2.0673%
37.2525%
2.7776%
0.3776%
5.9852%
-61.997%
-55.6575%
581.25%
9.0909%
0%
0%
0%
0%
0%
-36.1445%
70.8545%
-11.7251%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.